MELVILLE, New York--Henry Schein, a distributor of health-care products and services to office-based practitioners, has announced the promotion of Sergio Tejeda to director of regulatory operations and compliance. Tejeda joined Henry Schein in 1990 and spent his first eight years as the returns supervisor at the Port Washington Distribution Center. In 2006, he was promoted to regulatory affairs manager and assumed responsibility for the regulatory affairs team at GIV (General Injectables & Vaccines), a Henry Schein company. During the past few years, Tejeda has been instrumental in driving company-wide regulatory initiatives such as pharmaceutical pedigree, Verified-Accredited Wholesaler Distributors certification, DEA’s Suspicious Order Monitoring enhancements, and GIV’s repackaging/kitting operation. In his expanded role, in addition to his ongoing operational compliance responsibilities, Tejeda will be responsible for the oversight and management of Henry Schein’s adverse event and product quality processes and related regulatory activities. In this area, his initial focus will be to integrate and centralize this function with the company’s other core regulatory operations to identify opportunities, leverage resources, and globalize best practices. He earned a B.A. in criminal justice from Adelphi University. Tejeda, who resides in Washington, will be based at Henry Schein’s corporate headquarters in Melville. For more information, visit the Henry Schein Web site at www.henryschein.com.To read more about Henry Schein, go to Henry Schein.To comment on this topic, go to community.pennwelldentalgroup.com/.